M & As this week: Pelican Therapeutics, Thru Pharma
Clinical-stage biopharmaceutical company Heat Biologics has signed a definitive agreement to purchase 80% stake in US-based immuno-oncology company Pelican Therapeutics.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer & Oncology | Pharmaceuticals